جستجوی استاد راهنمای دانشگاهی

Russ Cucinaمشاهده پروفایل

استاد

• Medical Informatics
• Genomics
• Healthcare Analytics
• +۴ مورد دیگر

Russ Cucina, MD, MS, is a Professor of Medicine in the Division of Hospital Medicine at the University of California, San Francisco (UCSF). He holds dual roles as Vice President and Chief Health Information Officer for UCSF Health System, overseeing analytics, software infrastructure, and genetic/genomic services. His academic and professional focus integrates clinical informatics, healthcare technology, and genomic medicine to advance patient care and institutional missions. Dr. Cucina's education includes an MD from UC Davis, an MS in Biomedical Informatics from Stanford, and a BA in Molecular and Cell Biology from UC Berkeley. He is board-certified in Internal Medicine. His research interests span electronic health record (EHR) interventions, clinical decision support systems, pharmacogenomics implementation, and healthcare operations optimization. Notable achievements include the 2010 Distinguished Paper Award from the American Medical Informatics Association and the AMDIS Award for clinical informatics excellence. His work emphasizes translating data-driven solutions into actionable clinical practices, such as reducing telemetry overuse and improving discharge processes. Dr. Cucina leads UCSF's genetics/genomics laboratories and strategic partnerships in health IT. He is a vocal advocate for leveraging technology to enhance healthcare quality and accessibility, with a focus on personalized medicine and system-wide informatics advancements.

• Infectious Diseases
• Clinical Microbiology
• Antibiotic Resistance
• +۵ مورد دیگر

Jan-Erik Berdal is an Associate Professor at the Faculty of Medicine, University of Oslo, affiliated with the Department of Microbiology and Infectious Diseases. His research focuses on infectious disease epidemiology, antibiotic resistance, and critical care microbiology, with extensive contributions to understanding hospital-acquired infections, sepsis, and SARS-CoV-2 dynamics. He collaborates with Akershus University Hospital and participates in multinational studies like ISARIC-COVID-19. Research interests include: Microbial pathogenesis in critical care settings Antibiotic therapy and resistance patterns Viral infections and immune responses (notably SARS-CoV-2) Development of diagnostic tools for infections Recent publications highlight his work on fecal microbiota transplantation for C. difficile , longitudinal transcriptomics in COVID-19, and biomarker utility in predicting outcomes. Studies span clinical trials, cohort analyses, and computational biology tools. Key collaborations include institutions across Norway and international networks (e.g., ISARIC). His work bridges clinical microbiology, public health, and data-driven diagnostics, emphasizing real-world applications in hospital settings.

• Infectious Diseases
• Antibiotic Stewardship
• Clinical Trials
• +۴ مورد دیگر

Dr. Todd C. Lee is a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and an Associate Professor in the Department of Medicine , Faculty of Medicine and Health Sciences , McGill University . His work bridges clinical practice and research, focusing on infectious diseases , antibiotic stewardship , and quality improvement in hospitalized patients. He has led randomized trials on COVID-19 , C. difficile , and Staphylococcus aureus infections, emphasizing resource optimization and deprescribing practices. Key Research Areas: Antibiotic Resistance, Clinical Trials, Polypharmacy, Healthcare Resource Use Notable Contributions: Development of electronic decision support tools for deprescribing (e.g., MedSafer), hydroxychloroquine trials for COVID-19, and studies on urinary catheter reduction. Recent Publications: Focus on adaptive platform trials (DOTS, Staphylococcus aureus Network), antimicrobial synergy, and diagnostics for Pneumocystis jirovecii pneumonia. Email: todd.lee@mcgill.ca

Yogitha Srikhantaمشاهده پروفایل

پژوهشگر ارشد

• Bacterial Pathogenesis
• Epigenetics
• Antibiotic Resistance
• +۳ مورد دیگر

Dr. Yogitha Srikhanta is a Level B postdoctoral researcher and Research Fellow in the Department of Microbiology at Monash University's Faculty of Medicine, Nursing and Health Sciences. She leads multiple research projects focusing on bacterial pathogenesis, particularly Clostridioides difficile , and supervises 4 PhD students. Her work contributes to Sustainable Development Goals related to good health and well-being. Dr. Srikhanta's educational background includes: PhD from the University of Queensland (2007), supervised by Prof. Michael Jennings Her research interests focus on the genetic and molecular basis of bacterial pathogenesis, with particular expertise in epigenetic-mediated gene regulation, virulence gene characterization, novel vaccine candidates, and antibiotic resistance mechanisms. She is recognized as a world leader in bacterial epigenetics, having been the first to report on a novel bacterial epigenetic regulator during her PhD studies. Her current work primarily investigates C. difficile sporulation and antimicrobial resistance (AMR), with significant contributions to understanding how epigenetic mechanisms regulate virulence in gut pathogens. Dr. Srikhanta's publication record demonstrates consistent high-impact contributions to microbiology, with work appearing in journals such as Nature Microbiology, Nature Communications, and PNAS. Her research shows a clear trajectory from fundamental bacterial epigenetics to translational applications in combating antibiotic-resistant infections, particularly focusing on C. difficile . Recent work has explored cephamycin-based antisporulation agents and multi-omics approaches to understanding hospital-acquired diarrheal diseases. Her scientific recognition includes: Fellow of the Australian Society for Microbiology (2014) Griffith University Postdoctoral Fellowship (2009) Monash Emerging Academic Leaders Program (2018) Multiple Monash Platform Access Grants Dr. Srikhanta actively contributes to the academic community through research supervision, peer review activities (including for NHMRC and ARC), and professional service. She currently leads or participates in multiple research projects, including "The role of microbial interactions in controlling bacterial evolution" (2025-2027) and "The role of host proteases in exacerbating enteric infectious disease" (2021-2024). Her laboratory work focuses on understanding the molecular mechanisms of bacterial sporulation and antibiotic resistance, with the goal of developing novel therapeutic approaches against difficult-to-treat bacterial infections.

• Microbial Genomics
• Public Health
• Antimicrobial Resistance
• +۱۲ مورد دیگر

Alexandra Isabel Cardoso Nunes is a researcher at the Genomics and Bioinformatics Unit of the Department of Infectious Diseases at the Portuguese National Institute of Health (INSA), and an invited professor at the Faculty of Veterinary Medicine and the School of Psychology and Life Sciences at Lusófona University (ULusófona). She is actively involved in national and international research projects under the One Health framework, particularly in antimicrobial resistance, pathogen genomics, and outbreak surveillance. Her research interests span Microbial Genomics, Public Health, Antimicrobial Resistance (AMR), Bioinformatics, Pathogen Evolution, and One Health . She employs advanced genomic and transcriptomic techniques to study bacterial and viral pathogens, with a focus on Chlamydia trachomatis , Salmonella , Campylobacter , Mycobacterium tuberculosis , and SARS-CoV-2 . Her work integrates laboratory and computational methods for integrative surveillance and drug development. Her recent publications highlight trends in zoonotic pathogen transmission, AMR in food-producing animals, genomic surveillance of emerging outbreaks (e.g., mpox, SARS-CoV-2), and development of novel antimicrobial materials . These studies are increasingly interdisciplinary, combining veterinary, human, and environmental health perspectives under the One Health umbrella. European ERA-NET PathoGenoMics Ph.D. Award 2011 Gold Medal for Distinguished Services from the Portuguese Ministry of Health ASA Travel Award 2014 Nunes has (co-)supervised 27 students, including postdoctoral researchers, PhD, MSc, and BSc candidates, and currently mentors 10 students. She has participated in over 30 national and international research projects, including EU4Health, Horizon 2020, and ECDC-funded initiatives. She is a member of COST Action CA21145 'EURESTOP' and the Animal and Veterinary Research Centre (CECAV). She leads the development of bioinformatics tools like INSaFLU-TELEVIR for viral genomic surveillance and is co-inventor of a European patent on surfactant-based hydrogels for infection prevention. Her work bridges research, public health policy, and technological innovation.

Garry Blakelyمشاهده پروفایل

استاد

• Bacterial Genetics
• Genomics
• Biochemistry
• +۴ مورد دیگر

Professor Garry Blakely serves as Chair of Microbial Genetics and Biotechnology at the University of Edinburgh, where he has maintained an active research program since 1999. His work bridges fundamental bacterial genetics with translational applications in biomedicine and industrial biotechnology, focusing on pathogenic bacteria including Bacteroides , Clostridium , Staphylococcus , and Streptococcus . His academic foundation includes: Ph.D. from Queens University of Belfast (1990) MRC postdoctoral research at University of Glasgow (1990-1994) MRC postdoctoral research at University of Oxford (1994-1998) Wellcome Trust RCD Fellowship (1998-2002) Blakely's research centers on four interconnected themes: bacterial chromosome dynamics, restriction-modification systems, polysaccharide biosynthesis, and host-microbiome crosstalk. His laboratory pioneered genetic tools for manipulating anaerobic pathogens like B. fragilis and C. difficile , revealing mechanisms of DNA damage response critical to antibiotic efficacy. The landmark discovery of BfUbb—a bacterial ubiquitin homologue with antimicrobial properties—established a novel molecular link between gut microbiota and autoimmune disorders such as lupus and rheumatoid arthritis through antigenic mimicry. Analysis of his 2013-2019 publications reveals consistent thematic evolution: early work focused on restriction-modification systems and chromosome biology, while later research expanded into microbiome-autoimmunity connections and biotechnological applications like antimicrobial coatings. His studies integrate genomic, biochemical, and clinical approaches across fundamental microbiology, immunology, and materials science. Scientific recognition includes: Wellcome Trust RCD Fellowship Blakely actively supervises PhD students and secures collaborative funding from medical research councils and industry partners. His projects translate basic discoveries into novel biotechnological solutions, including engineered bacterial strains for compound production and medical device coatings that prevent bacterial adhesion. Current grants support investigations into BfUbb's role in autoimmune pathogenesis and development of next-generation antimicrobials targeting anaerobic pathogens. He leads a multidisciplinary research group within the University of Edinburgh's Roger Land Building, maintaining active collaborations with Queen's University Belfast and industrial partners to advance bacterial genetics research toward clinical and industrial applications.

• Infectious Diseases
• HIV/AIDS
• Tropical Medicine
• +۵ مورد دیگر

Antonio Cascio is a Full Professor in the Department of Infectious Diseases at the University of Palermo's School of Medicine and Surgery, specializing in Health Promotion, Maternal and Child, Internal Medicine, and Specialist Excellence "G. D'Alessandro." He serves as the Delegate for Health Policies related to the "One Health" theme and maintains active teaching responsibilities in Infectious Diseases for both medical and nursing programs. His office hours are held twice weekly at the Infectious Diseases Unit of AOU Policlinico "P. Giaccone" in Palermo. Professor Cascio's research spans multiple critical areas of infectious diseases with particular emphasis on HIV/AIDS, antimicrobial resistance, tropical medicine, and the epidemiology of infectious diseases. His work demonstrates a strong focus on the intersection of clinical practice and public health, with significant contributions to understanding viral infections, tuberculosis, and emerging pathogens. His recent publications reflect a growing interest in the One Health approach, examining connections between human, animal, and environmental health factors in disease transmission and management. The trajectory of his publication record, spanning from 1992 to 2025 with over 200 publications, reveals evolving research priorities that have adapted to global health challenges. Early work focused on rotavirus epidemiology and leishmaniasis, while more recent research addresses contemporary challenges including HIV drug resistance, antimicrobial resistance patterns, the impact of the COVID-19 pandemic, and innovative treatment approaches for complex infections. His international collaborations, particularly through the ID-IRI network, demonstrate a commitment to global health research and knowledge sharing. Professor Cascio maintains an active role in clinical practice, research, and teaching, with regular contributions to both Italian and international medical literature. His work frequently appears in high-impact journals covering infectious diseases, virology, and public health topics, reflecting his standing as a respected authority in his field.

Katie Lairdمشاهده پروفایل

استاد

• Microbiology
• Infectious Diseases
• Healthcare-Associated Infections (HAIs)
• +۱۲ مورد دیگر

Professor Katie Laird is a Professor of Microbiology and Head of the Infectious Disease Research Group at De Montfort University, affiliated with the Leicester School of Pharmacy within the Faculty of Health and Life Sciences. Her research significantly impacts infection control, particularly regarding healthcare textiles and antimicrobial resistance. Education: BSc (Hons) in Biology PhD in Applied Microbiology (2008) Research Interests: Prof. Laird's research centers on preventing healthcare-associated infections (HAIs), with a focus on the role of healthcare textiles as fomites. She investigates novel antimicrobials (including essential oils and nano-metals), biofilm formation, and the stability of pathogens like C. difficile and coronaviruses on textiles. Her work has directly informed global infection control policies, especially in industrial laundry settings. Publication Trends: Her recent articles reflect a strong emphasis on antimicrobial textiles, essential oil synergies, viral stability on fabrics, and molecular mechanisms of resistance. These works span microbiology, materials science, and public health, demonstrating interdisciplinary impact in combating antimicrobial resistance and improving hygiene protocols. Scientific Awards: DMU Future Research Leaders Fellow (2015) Outstanding Poster Award, American Society of Microbiology (2015) Medici Fellow – Birmingham University (2014) Chartered Biologist (2010) Fellow of the Higher Education Academy (2009) House of Commons Award for Research Excellence in HAIs (2008) Advising and Grants: Prof. Laird supervises multiple PhD students and has secured extensive funding from diverse sources including the Society for Applied Microbiology, Textile Services Association, National Biofilms Innovation Centre, and internal DMU funds (e.g., HEIF, GCRF). Her grants support projects on antimicrobial textiles, educational outreach (A Germ’s Journey), and infection control innovations. Labs and Teams: She leads the Infectious Disease Research Group at DMU and is the Lead for the Medilink East Midlands Infectious Disease Special Interest Group. Her team collaborates with global brands, trade bodies, and academic networks such as the EU COST Action CA16227 on mosquito-repellent textiles.

Michael Rajnikمشاهده پروفایل

استاد بالینی

• Pediatric Infectious Diseases
• Epidemiology
• Respiratory Tract Infections
• +۳ مورد دیگر

Dr. Michael Rajnik is a Clinical Professor of Pediatrics at the Uniformed Services University of the Health Sciences in Bethesda, MD. He serves as Division Director for Infectious Disease within the School of Medicine, with academic and clinical expertise focusing on pediatric infectious diseases, epidemiology, and global health initiatives. B.S. Chemistry, King's College (1991) M.D., University of Virginia School of Medicine (1995) Pediatrics Residency, Wilford Hall USAF Medical Center (1998) Pediatric Infectious Diseases Fellowship, National Capital Consortium/USUHS (2001) Dr. Rajnik's research spans pediatric infectious diseases with emphasis on respiratory tract infections, epidemiology, and global health. He has led studies on rotavirus immunization effectiveness, tuberculosis treatment innovations, and pandemic-related healthcare impacts across military populations. His work combines clinical research with public health surveillance and has shaped vaccination and infection control practices within military healthcare systems. Pediatric infectious diseases during wartime, vaccine-preventable illnesses, and multidrug-resistant infections form recurring themes in his research. Recent work focuses on COVID-19 pandemic effects across military pediatric and adult populations, including rotavirus hospitalization trends, cardiac complications, and sexually transmitted infection management. Scientific contributions and recognitions include: Chair, Infectious Diseases Institutional Review Board (2009-2016) Chair, American Academy of Pediatrics Executive Committee (2009-2014) President, Armed Forces Infectious Diseases Society (2007-2008) USAF Master Educator (2007, 2012) Educator of the Year, San Antonio Uniformed Services (2006) As a mentor and Fellowship Director (2006-2016), Dr. Rajnik has guided numerous military physicians in pediatric infectious diseases while leading research administration and advocating for military families within the American Academy of Pediatrics. His clinical and administrative roles demonstrate sustained commitment to advancing military pediatric medicine through education, research, and policy engagement.

Yuliya Vladimirovna Lokhnyginaمشاهده پروفایل

دانشیار

• Statistical methods in clinical trials
• survival analysis
• adaptive designs
• +۳ مورد دیگر

Yuliya Vladimirovna Lokhnygina serves as Associate Professor of Biostatistics & Bioinformatics at Duke University, where she is a key member of the Duke Clinical Research Institute (DCRI) and Biostatistics, Epidemiology, and Research Design (BERD) Methods Core. Her office is located at 200 Morris Street, Durham, NC, and she contributes statistical expertise to clinical research across multiple medical disciplines. Her academic foundation includes: Ph.D. in Statistics from North Carolina State University (2004) M.S. in Statistics from Cornell University (2001) M.S. in Applied Mathematics from Moscow Institute of Physics and Technology, Russia (1999) Dr. Lokhnygina's research centers on advanced statistical methodologies for clinical investigations, with core expertise in survival analysis, adaptive clinical trial designs, causal inference in observational studies, and semiparametric inference. Her methodological innovations directly address challenges in complex clinical settings, particularly in infectious disease management and transplantation medicine. Analysis of her 2024-2025 publications reveals a strong focus on clinical trial methodology (win statistics for hierarchical endpoints), nephrology (kidney transplantation disparities), infectious diseases (antifungal strategies, HIV care during pandemics), and surgical outcomes. Her work consistently bridges theoretical biostatistics with practical clinical applications through high-impact collaborations. She currently leads 27 major research grants including NIH R01 awards for antifungal strategies (LAmB-FAST), neonatal malaria testing (INTREPiD), and kidney transplant equity (STEPS), alongside AHRQ-funded studies on C. difficile prevention and PCORI-supported interventions for living kidney transplants. These projects demonstrate substantial funding support and interdisciplinary collaboration across Duke and national institutions. Within the BERD Methods Core and DCRI, Dr. Lokhnygina operates in a premier clinical research ecosystem that supports over 500 active studies. Her role involves statistical leadership for large-scale trials including TACT2 (chelation therapy) and Limbix Spark (digital mental health interventions), contributing to Duke's reputation in translational research.

Ana M. Vaughan-Malloyمشاهده پروفایل

مدرس

• Hospital Epidemiology
• Infection Prevention and Control
• Healthcare-associated Infections
• +۳ مورد دیگر

Ana M. Vaughan-Malloy is an Instructor of Pediatrics at Harvard Medical School and an Associate Hospital Epidemiologist at Boston Children's Hospital. She holds roles as Assistant in Pediatrics (Division of Infectious Diseases) and Associate Medical Director of Infection Prevention and Control. Dr. Vaughan-Malloy completed her MD at the Perelman School of Medicine (University of Pennsylvania) and MPH at the University of California, Berkeley. Her residency and chief residency were at Phoenix Children’s Hospital, followed by a pediatric infectious diseases fellowship at Children’s Hospital of Philadelphia. Her research focuses on hospital epidemiology, infection prevention strategies, and quality improvement initiatives targeting healthcare-associated infections. Key areas include antibiotic stewardship, catheter-associated infections, and human factors influencing hand hygiene compliance. She has contributed to multicenter collaborative studies on pediatric antibiotic prescribing and developed innovative tools like Kamishibai cards for infection control. Dr. Vaughan-Malloy’s work integrates clinical practice with research, addressing critical gaps in pediatric infectious diseases and infection control protocols. Her recent publications emphasize standardized evaluation protocols for acute tracheitis in ventilated children and CLABSI prevention strategies. She actively participates in hospital-wide initiatives to enhance patient safety through evidence-based practices. Professional certifications include the American Board of Pediatrics (General). Her clinical practice emphasizes patient-centered care, advocacy, and continuous learning. She is affiliated with Boston Children’s Hospital’s Division of Infectious Diseases and collaborates with the Department of Infection Prevention and Control to advance hospital epidemiology efforts.

Christopher Chiuمشاهده پروفایل

استاد

• Immunology
• Medical Microbiology
• Clinical Sciences
• +۳ مورد دیگر

Prof. Christopher Chiu is a Professor of Infectious Diseases and Immunology at Imperial College London's Faculty of Medicine. His research focuses on respiratory viral infections (RSV, influenza, SARS-CoV-2), pathogenesis, and vaccine development. He leads the CEPI-HERA MusICC consortium and the Imperial Network for Vaccine Research, collaborating internationally on vaccines and human challenge studies. His work combines clinical trials with experimental medicine techniques to study immune responses, particularly mucosal and systemic immunity. Education: MA (Cambridge), BMBCh (Oxford), MSc (Queen Mary), PhD (Imperial College London). Affiliations: Immuno-Pathology Network, Vaccine Research Network, Section of Adult Infectious Disease. His research integrates controlled human infection models (CHIs) to assess vaccine efficacy and correlates of protection. Key projects include studying immune responses to respiratory pathogens and developing biomarkers for disease severity. He has pioneered methodologies to analyze viral kinetics and host immunity, contributing to global pandemic preparedness efforts. Awards: Wellcome Trust Clinical Research Training Fellowship, MRC Clinician Scientist Fellowship. Prof. Chiu’s lab investigates immunological mechanisms behind asymptomatic vs. severe infections, with a focus on B/T cell responses and viral interactions. He is a key figure in regulatory and collaborative initiatives advancing vaccine research and clinical trial standards.

• Biomedical Research
• Physical Chemistry
• Analytical Chemistry
• +۷ مورد دیگر

Mayland Chang is a Research Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, within the College of Science. Her research spans biomedical chemistry, focusing on therapeutic interventions for chronic diseases and antibiotic-resistant infections. Research Interests: Understanding the molecular basis of diabetic wound healing through matrix metalloproteinase (MMP) activity, particularly MMP-8 and MMP-9. Designing novel small-molecule therapeutics such as ND-336 for diabetic foot ulcers. Developing new classes of antibiotics including quinazolinones and oxadiazoles to combat MRSA and Clostridioides difficile . Targeting bacterial resistance mechanisms, especially PBP2a in MRSA and spore germination pathways in C. difficile . The recent publications show a consistent trend in targeting pathogenic mechanisms at the molecular level, combining quantitative proteomics, enzyme kinetics, and in vivo evaluation. Her work bridges chemistry and translational medicine, aiming to deliver clinically relevant therapeutics. Scientific Leadership: Director, CBBI Program (2007–2022) Dr. Chang mentors graduate students and welcomes prospective applicants to join her lab. She has secured long-term research funding enabling sustained projects in antibiotic development and wound healing. Her collaborative work with Prof. Shahriar Mobashery highlights a strong interdisciplinary team approach. She is actively involved in cutting-edge research with ongoing projects identifying active MMPs in diabetic patients and optimizing oxadiazole compounds for C. difficile treatment.

Eva Ennsمشاهده پروفایل

دانشیار

• Infectious disease
• mathematical modeling
• cost-effectiveness
• +۴ مورد دیگر

Eva Enns is an Associate Professor in the Division of Health Policy & Management at the University of Minnesota School of Public Health. Her work focuses on developing mathematical models of infectious disease transmission to inform public health policy and intervention strategies. Her educational background includes: PhD in Electrical Engineering, Stanford University, 2012 MS in Electrical Engineering, Stanford University, 2008 BSc in Electrical Engineering, Massachusetts Institute of Technology, 2006 Eva Enns specializes in mathematical modeling of infectious disease spread, with particular expertise in HIV/AIDS, sexually transmitted infections (STIs), and cost-effectiveness analysis of public health interventions. Her research employs network analysis and model calibration techniques to evaluate strategies for disease prevention, management, and control. She has developed methodologies to address infectious disease outbreaks through sophisticated computational approaches that bridge engineering principles with public health applications. Her work has significant implications for healthcare policy development and resource allocation in epidemic response. Analysis of her recent publications reveals a strong focus on HIV/AIDS interventions, cost-effectiveness of medical treatments, and mathematical modeling of infectious disease transmission. Her research spans multiple disciplines including epidemiology, health economics, and computational modeling, with particular emphasis on translating complex mathematical models into actionable public health policy recommendations. She frequently collaborates with interdisciplinary teams to address pressing infectious disease challenges. Dr. Enns maintains an active research program with consistent publication output across high-impact journals in infectious disease modeling and health policy, demonstrating her significant contributions to the field. Dr. Enns advises students in the Division of Health Policy & Management and collaborates with various research teams on infectious disease modeling projects. Her work bridges the gap between engineering methodologies and public health applications, creating novel approaches to understanding and mitigating infectious disease spread. Her research is conducted within the Division of Health Policy & Management at the University of Minnesota School of Public Health, where she contributes to the department's mission of improving population health through evidence-based policy analysis and development.

Mark Howarthمشاهده پروفایل

استاد

• Vaccines
• Protein Engineering
• Synthetic Biology
• +۷ مورد دیگر

Professor Mark Howarth is the Sheild Chair of Pharmacology at the University of Cambridge's Department of Pharmacology. His research focuses on innovating protein technologies for therapeutic and vaccine design, with affiliations across the Cambridge Infectious Diseases interdisciplinary center and collaborations spanning North America, Europe, and biotech/pharma industries. Research Highlights: Vaccine development platforms applied to SARS-CoV-2, influenza, malaria, HIV, and veterinary diseases Gastrobodies for targeting gastrointestinal infections through acid-resistant antibody mimetics Protein superglues (SpyTag/SpyCatcher) enabling synthetic biology and antibody team engineering NeissLock technology for covalent protein targeting in cancer immunotherapy Scientific Achievements: Royal Society of Chemistry Norman Heatley Prize Founder of SpyBiotech (now in clinical trials) Technologies adopted by over 1000 academic groups and biotech companies Lab Members: Gabrielle Admans, Claudia Driscoll, Rory Hills, Anthony Keeble, Lasya Vankayala, Deepak Chand, Yujia Cui, Emily Nassen, Dawid Maciorowski, Ana Rossi